当前位置: 首页? 政策法规? 国外法规? (EU) No 379/2012:拒绝批准某些用于食品涉及降低疾病风险和儿童成长、健康有关的声称(refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health)

(EU) No 379/2012:拒绝批准某些用于食品涉及降低疾病风险和儿童成长、健康有关的声称(refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health)

扫描二维 分享好友和朋友圈
放大字体缩小字体2015-01-15 01:57:58 来源9a href="http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1421194548482&uri=CELEX:32012R0379" target="_blank" rel="nofollow">EUROPE浏览次数9span id="hits">3172
核心提示?012??日,欧盟发布委员会条?EU) No 379/2012,拒绝批?种食品健康声称:分别如下?)鼠李糖乳杆菌GG有助于防御肠道病原体?)特有的胶原蛋白肽混合物(水解胶原蛋白)对维持爱好运动人群的关节健康具有有益生理作用、/div>
发布单位
EUROPEAN COMMISSION
EUROPEAN COMMISSION
发布文号 (EU) No 379/2012
发布日期 2012-05-04 生效日期 暂无
有效性状?/th> 废止日期 暂无
备注 2012??日,欧盟发布委员会条?EU) No 379/2012,拒绝批?种食品健康声称:分别如下?)鼠李糖乳杆菌GG有助于防御肠道病原体?)特有的胶原蛋白肽混合物(水解胶原蛋白)对维持爱好运动人群的关节健康具有有益生理作用、/td>

  COMMISSION REGULATION (EU) No 379/2012

  of 3 May 2012

  refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to childrens development and health

  (Text with EEA relevance)

  THE EUROPEAN COMMISSION,

  Having regard to the Treaty on the Functioning of the European Union,

  Having regard to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods (1), and in particular Article 18(5) thereof,

  Whereas:

  (1)

  Pursuant to Regulation (EC) No 1924/2006 health claims made on foods are prohibited unless they are authorised by the Commission in accordance with that Regulation and included in a list of permitted claims.

  (2)

  Regulation (EC) No 1924/2006 also provides that applications for authorisations of health claims may be submitted by food business operators to the national competent authority of a Member State. The national competent authority is to forward valid applications to the European Food Safety Authority (EFSA), hereinafter referred to as the Authority.

  (3)

  Following receipt of an application the Authority is to inform without delay the other Member States and the Commission thereof and to deliver an opinion on the health claim concerned.

  (4)

  The Commission is to decide on the authorisation of health claims taking into account the opinion delivered by the Authority.

  (5)

  Following an application from Valio Ltd, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of Lactobacillus rhamnosus GG (LGG) on maintenance of defence against pathogenic gastrointestinal micro-organisms (Question No EFSA-Q-2010-01028) (2). The claim proposed by the applicant was worded as follows: Lactobacillus GG helps to maintain defence against intestinal pathogens.

  (6)

  On 1 June 2010, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of Lactobacillus rhamnosus GG and the claimed effect. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.

  (7)

  Following an application from Gelita AG, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of collagen hydrolysate on maintenance of joints (Question No EFSA-Q-2011-00201) (3). The claim proposed by the applicant was worded as follows: Characteristic collagen peptide mixture (collagen hydrolysate) having a beneficial physiological effect on the maintenance of joint health in physically active people.

  (8)

  On 20 July 2011, the Commission and the Member States received the scientific opinion from the Authority, which concluded that on the basis of the data presented, a cause and effect relationship had not been established between the consumption of collagen hydrolysate and the claimed effect. Accordingly, as the claim does not comply with the requirements of Regulation (EC) No 1924/2006, it should not be authorised.

  (9)

  The health claims subject to this Regulation are health claims as referred to in point (a) of Article 13(1) of Regulation (EC) No 1924/2006 and may benefit from the transitional period laid down in Article 28(5) of that Regulation. As the Authority concluded that cause and effect relationships have not been established between the foods and the claimed effects, the claims do not comply with Regulation (EC) No 1924/2006, and therefore they may not benefit from the transitional period provided for in that Article.

  (10)

  In order to ensure that this Regulation is fully complied with, both food business operators and the national competent authorities should take the necessary actions to ensure that, at the latest six months following the entry into force of this Regulation, the health claims listed in its Annex are no longer used.

  (11)

  The comments from the applicants and the members of the public received by the Commission pursuant to Article 16(6) of Regulation (EC) No 1924/2006 have been considered when setting the measures provided for in this Regulation.

  (12)

  The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health and neither the European Parliament nor the Council have opposed them,

  HAS ADOPTED THIS REGULATION:

  Article 1

  1. The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.

  2. However, the health claims referred to in paragraph 1 used prior to the entry into force of this Regulation may continue to be used for a maximum period of six months after the entry into force of this Regulation.

  Article 2

  This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

  This Regulation shall be binding in its entirety and directly applicable in all Member States.

  Done at Brussels, 3 May 2012.

  For the Commission

  The President

  Jos Manuel BARROSO

ANNEX
Rejected health claims
Application Relevant provisions of Regulation (EC) No 1924/2006
Nutrient, substance, food or food category
Claim
EFSA opinion reference
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Lactobacillus rhamnosus GG (LGG)
Lactobacillus GG helps to maintain defence against intestinal pathogens
Q-2010-01028
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Collagen hydrolysate
Characteristic collagen peptide mixture (collagen hydrolysate) having a beneficial physiological effect on the maintenance of joint health in physically active people
Q-2011-00201


地区9/font>欧盟
标签9/font>疾病风险声称胶原蛋白健康声称
食品伙伴网提供标准法规解读、舆情监控、合规咨询、申报注册等服务、br/>电询?535-2129301
QQ?891238009
食品标法? border=
实时把握 食品标法动?/span>
请扫码关?span class="color2">食品标法圇/span>

声明9/p>

凡本网所有原?编译文章及图片、图表的版权均属食品伙伴网所有,如要转载,需注明“信息来源:食品伙伴网”、br> 凡本网注明“信息来源:XXX(非食品伙伴网)”的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责、br> 邮箱:law#www.sqrdapp.com(发邮件时请?换成@ QQ?39307733

[ 政策法规搜索] [ 加入收藏] [ 告诉好友] [ 打印本文] [ 关闭窗口]

Baidu
map